Recap: BioLine Rx Q2 Earnings

BioLine Rx BLRX reported its Q2 earnings results on Tuesday, August 16, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

BioLine Rx missed estimated earnings by 114.29%, reporting an EPS of $-0.15 versus an estimate of $-0.07.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 1.89% increase in the share price the next day.

To track all earnings releases for BioLine Rx visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.